We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

644 hedge funds and large institutions have $13.5B invested in Charles River Laboratories in 2022 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 262 increasing their positions, 235 reducing their positions, and 115 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 262 | Existing positions reduced: 235

0.8% more ownership

Funds ownership: 93.47% → 94.28% (+0.8%)

1% less call options, than puts

Call options by funds: $77.7M | Put options by funds: $78.4M

9% less funds holding

Funds holding: 707 → 644 (-63)

24% less capital invested

Capital invested by funds: $17.7B → $13.5B (-$4.23B)

48% less first-time investments, than exits

New positions opened: 60 | Existing positions closed: 115

53% less funds holding in top 10

Funds holding in top 10: 15 → 7 (-8)

Holders
644
Holders Change
-63
Holders Change %
-8.91%
% of All Funds
10.16%
Holding in Top 10
7
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-53.33%
% of All Funds
0.11%
New
60
Increased
262
Reduced
235
Closed
115
Calls
$77.7M
Puts
$78.4M
Net Calls
-$664K
Net Calls Change
-$48.1M

Top Buyers

1
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$171M
2
ClearBridge Investments
ClearBridge Investments
New York
+$92.9M
3
Fidelity International
Fidelity International
Bermuda
+$83.3M
4
Two Sigma Investments
Two Sigma Investments
New York
+$53.3M
5
JMPWA
JP Morgan Private Wealth Advisors
California
+$47M

Top Sellers

1
Invesco
Invesco
Georgia
-$142M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$118M
3
Brown Advisory
Brown Advisory
Maryland
-$111M
4
Marshall Wace
Marshall Wace
United Kingdom
-$86.9M
5
ESCM
Echo Street Capital Management
New York
-$65.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
26
TimesSquare Capital Management
New York
$91.4M -$17.7M -57,250 -15%
Legal & General Group
27
Legal & General Group
United Kingdom
$89.2M +$3.48M +11,273 +4%
MBI
28
Montrusco Bolton Investments
Quebec, Canada
$85.3M +$42M +136,231 +81%
Charles Schwab
29
Charles Schwab
California
$81.8M +$4.28M +13,865 +5%
Brown Advisory
30
Brown Advisory
Maryland
$79.2M -$111M -360,156 -56%
HKAM
31
Horizon Kinetics Asset Management
New York
$78.2M +$14.8M +47,933 +21%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$77.3M -$4.27M -13,837 -5%
Two Sigma Investments
33
Two Sigma Investments
New York
$74.1M +$53.3M +172,737 +196%
RP
34
Riverbridge Partners
Minnesota
$73.6M +$27.2M +88,183 +52%
JP Morgan Chase
35
JP Morgan Chase
New York
$72.5M +$30.7M +99,525 +64%
Fisher Asset Management
36
Fisher Asset Management
Washington
$70.5M -$1.01M -3,268 -1%
Neuberger Berman Group
37
Neuberger Berman Group
New York
$69.9M -$6.44M -20,877 -8%
Alyeska Investment Group
38
Alyeska Investment Group
Illinois
$68.9M +$16.1M +52,319 +28%
Millennium Management
39
Millennium Management
New York
$65.8M +$4.83M +15,668 +7%
Deutsche Bank
40
Deutsche Bank
Germany
$64M +$2.22M +7,187 +3%
Citadel Advisors
41
Citadel Advisors
Florida
$63.8M +$7.47M +24,222 +12%
T. Rowe Price Associates
42
T. Rowe Price Associates
Maryland
$62.8M +$583K +1,892 +0.9%
Swiss National Bank
43
Swiss National Bank
Switzerland
$62.1M +$8.33M +27,000 +14%
AI
44
Ariel Investments
Illinois
$59.6M +$9.3M +30,148 +17%
VBA
45
Van Berkom & Associates
Quebec, Canada
$57.2M -$6.34M -20,553 -9%
Federated Hermes
46
Federated Hermes
Pennsylvania
$55.3M -$6.16M -19,988 -9%
Morgan Stanley
47
Morgan Stanley
New York
$54.8M -$1.85M -5,994 -3%
First Trust Advisors
48
First Trust Advisors
Illinois
$53.8M -$28.2M -91,371 -33%
Victory Capital Management
49
Victory Capital Management
Texas
$53M -$12.7M -41,113 -18%
BNP Paribas Asset Management
50
BNP Paribas Asset Management
France
$52.8M +$3.82M +12,387 +7%
1
2
3 4 5

CRL Hedge Fund Activity: Q1 2022 in Review

644 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2022, worth a combined $13.5B — down 24% from $17.7B a quarter earlier.

Sellers outnumbered buyers: 115 funds closed out of CRL and 60 opened new positions — a net loss of 55 holders — while 235 trimmed existing stakes and 262 added.

The largest buyer was Mackenzie Financial, adding an estimated $171M. The largest seller was Invesco, cutting an estimated $142M.

  • 644 institutional investors held Charles River Laboratories (CRL) as of Q1 2022, down from 707 in Q4 2021.
  • Funds reported $13.5B of Charles River Laboratories stock for Q1 2022, down 24% quarter-over-quarter.
  • 60 funds opened new Charles River Laboratories positions in Q1 2022 and 115 closed out, a net change of -55 holders.
  • The largest Charles River Laboratories buyer in Q1 2022 was Mackenzie Financial, an estimated $171M added.
  • The largest Charles River Laboratories seller in Q1 2022 was Invesco, an estimated $142M sold.

Based on aggregated 13F filings for Q1 2022.